Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/31/2009US20090325916 5-aryl indan-1-one and analogs useful as progesterone receptor modulators
12/31/2009US20090325915 Crystalline Levosalbutamol Sulphate and Polymorphic Forms Thereof
12/31/2009US20090325914 Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
12/31/2009US20090325913 Treatment of pain using satraplatin
12/31/2009US20090325912 Quinolinone derivatives and their pharmaceutical compositions
12/31/2009US20090325911 Use of Androgens for the Treatment of Parkinson's Disease
12/31/2009US20090325910 Compositions and methods for tranquilizing heart muscle
12/31/2009US20090325909 Suppression of HIV replication and prevention and treatment of HIV
12/31/2009US20090325908 9-substituted minocycline compounds
12/31/2009US20090325907 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
12/31/2009US20090325906 Methods and compositions for therapeutic treatment
12/31/2009US20090325905 Method for treating diseases associated with alterations in cellular integrity using rho kinase inhibitor compounds
12/31/2009US20090325904 Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same
12/31/2009US20090325903 Boronate ester compounds and pharmaceutical compositions thereof
12/31/2009US20090325902 Heterocyclic urea derivatives and methods of use thereof
12/31/2009US20090325901 Improvements in pharmaceutical compositions
12/31/2009US20090325900 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
12/31/2009US20090325899 Medical composition for protuberance of epithelium
12/31/2009US20090325898 Skin material for external use and antiprutiric agent for external use and wrinkle-instrument using the same
12/31/2009US20090325897 Designer therapy of pancreatic tumors
12/31/2009US20090325896 Partial and full agonists of a1 adenosine receptors
12/31/2009US20090325895 Methods of treating an inflammatory-related disease
12/31/2009US20090325894 Tetracyclic anthraquinones possessing anti-cancer properties
12/31/2009US20090325893 Doxorubicin adjuvants to reduce toxicity and methods for using the same
12/31/2009US20090325891 Cartilage regeneration-promoting agent
12/31/2009US20090325890 Use of galactose c-glycoside derivatives as protective agent and/or gama delta t lymphocyte activator
12/31/2009US20090325880 Tnf receptor-like molecules and uses thereof
12/31/2009US20090325879 Controlled release copolymer formulation with improved release kinetics
12/31/2009US20090325878 Organ preconditioning, arrest, protection, preservation and recovery
12/31/2009US20090325877 Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer
12/31/2009US20090325876 Use of lipid conjugates in the treatment of diseases associated with vasculature
12/31/2009US20090325870 Foamy viral envelope genes
12/31/2009US20090325868 Materials And Methods For FOXP3 Tumor Suppression
12/31/2009US20090325862 Histone Deacetylase Inhibitors for the Treatment of Neurodegeneration
12/31/2009US20090325858 Reduction of Zinc-Induced Neurotoxic Injury By Blockade of Nitric Oxide Synthesis
12/31/2009US20090325857 Use of opioid receptor antagonists
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/31/2009US20090324760 Hair tonic
12/31/2009US20090324758 Plant extract mixtures and their uses
12/31/2009US20090324757 Compositions and Methods for Modulating Visceral Sensation and/or Gastrointestinal Reflex Activity
12/31/2009US20090324754 Eucalyptus extract, method of preparation and therapeutic uses thereof
12/31/2009US20090324751 Chinese herb extract for treating dementia and preparation method thereof
12/31/2009US20090324750 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
12/31/2009US20090324748 Trauma therapy
12/31/2009US20090324744 Effective Antitumor Treatments
12/31/2009US20090324742 Peham dendrimers as excipients
12/31/2009US20090324741 Injectable polymer-lipid blend
12/31/2009US20090324740 Novel nasal spray
12/31/2009US20090324736 Methods of treating bowel diseases by administering a bowel cleanser and an antibiotic
12/31/2009US20090324729 Use of solid carrier particles to improve the processability of a pharmaceutical agent
12/31/2009US20090324728 Pharmaceutical compositions comprising amorphous benzimidazole compounds
12/31/2009US20090324727 Nanoemulsion
12/31/2009US20090324726 Non-Viral Gene Therapy Using Chitosan-Containing Nanoparticles
12/31/2009US20090324725 Peg-modified hydroxyapatite, pharmaceutical using the same as base material and production process thereof
12/31/2009US20090324724 Soluble amide & ester pyrazinoylguanidine sodium channel blockers
12/31/2009US20090324721 Hydrogels Suitable For Use In Polyp Removal
12/31/2009US20090324720 Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
12/31/2009US20090324718 Imatinib compositions
12/31/2009US20090324717 Extended release pharmaceutical formulation of metoprolol and process for its preparation
12/31/2009US20090324715 High dose oral pharmaceutical compositions of artemether and lumefantrine
12/31/2009US20090324714 Dual adhesive technology
12/31/2009US20090324712 Methods and compositions related to production of coenzyme q10
12/31/2009US20090324711 Oral Pharmaceutical Composition of Anilinopyrimidine, Preparation and Use Thereof
12/31/2009US20090324710 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
12/31/2009US20090324709 Liposomal formulations
12/31/2009US20090324708 Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprising thereof and a method for the treatment of rho-gtpase cell protein-mediated condition
12/31/2009US20090324706 Nanostructures Suitable for Sequestering Cholesterol and Other Molecules
12/31/2009US20090324703 Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
12/31/2009US20090324701 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders
12/31/2009US20090324699 Antihistamine-and corticosteroid-containing lipsome composition and its use for the manufacture of medicament for treating rhinitis and related disorders
12/31/2009US20090324698 Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof
12/31/2009US20090324697 Transdermal hormone delivery system: compositions and methods
12/31/2009US20090324696 Nail patch
12/31/2009US20090324691 Methods and ophthalmic devices used in the treatment of ocular allergies
12/31/2009US20090324690 Transscleral delivery
12/31/2009US20090324689 inhibiting the transition from the dry form of age-related macular degeneration to the wet form with rapamycin or analogs such as AP 23841, zotarolimus, tacrolimus, everolimus, pimecrolimus, temsirolimus; implants
12/31/2009US20090324688 Transscleral delivery
12/31/2009US20090324687 Transscleral delivery
12/31/2009US20090324686 mTOR inhibitor effective to treat macular edema; rapamycin or analogs such as AP 23841, zotarolimus, tacrolimus, everolimus, pimecrolimus, temsirolimus; treatment of wet age related macular degeneration
12/31/2009US20090324682 Medical stent provided with inhibitors of atp synthesis
12/31/2009US20090324678 Methods and kits for treating joints and soft tissues
12/31/2009US20090324677 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
12/31/2009US20090324669 Osteogenic enhancer composition
12/31/2009US20090324664 Spray-on, non-woven fabric system and multilayer topical covering
12/31/2009US20090324658 Cosmetic and Method for Production Thereof
12/31/2009US20090324643 Compositions and methods for treating and preventing infection
12/31/2009US20090324631 Polyvalent Vaccine
12/31/2009US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES
12/31/2009US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
12/31/2009US20090324625 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/31/2009US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
12/31/2009US20090324618 Novel signature self renewal gene expression programs
12/31/2009US20090324612 Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
12/31/2009US20090324611 Targeting VEGF-B Regulation Of Fatty Acid Transporters To Modulate Human Diseases
12/31/2009US20090324610 Gene associated with arteriosclerotic disease, and use thereof
12/31/2009US20090324596 Methods of identifying and treating poor-prognosis cancers
12/31/2009US20090324587 Cancer Therapies and Pharmaceutical Compositions Used Therein
12/31/2009US20090324584 Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
12/31/2009US20090324583 Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation
12/31/2009US20090324581 Heteroarylamide lower carboxylic acid derivative
1 ... 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 ... 7860